CVS Health Corp

A look at where Parnassus Investments has focused its recent efforts.

We downgraded these three stocks, but they’re still undervalued.

We view shares of the narrow-moat firm as undervalued.

Automotive, tech, and healthcare earnings are out this week as are several Fed reports.

In part two of our three-part special report on value investing, our analysts share insights gleaned from fund manager interviews.

Here are our analysts' top ideas in each sector at the third quarter's end.

We see opportunities in providers, managed care, drugs, and biotech.

We find several actionable ideas that yield more than the S&P 500.

We recap the week on Morningstar.com and note the most popular stocks, funds, and ETFs.

We see risks for managed care but also opportunities to own moatworthy companies at sizable discounts.

The firm has new approaches to managing healthcare needs.

These high-quality names are trading at 5-star levels.

We're watching for Disney, Uber, and others this week.

We take a numerical look through this week's Morningstar research. Plus, our most popular articles and videos for the week ended July 5.

We're finding some opportunity in a sector that's fairly valued overall.

One stock graduated to narrow-moat status last month, while three others enjoyed fair value increases of 20% or more.

We think the pharmacy retailer can further leverage its significant scale.

Five types of opioid-related shareholder resolutions are currently on ballots.

We take a numerical look through this week's Morningstar research. Plus, our most popular articles and videos for the week ended April 12.

Here are some of our analysts' best ideas across sectors.